Published in Hepatology on September 01, 1993
Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol (1994) 1.13
Biglycan: a multivalent proteoglycan providing structure and signals. J Histochem Cytochem (2012) 1.12
Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease. World J Gastroenterol (2002) 1.06
Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease. J Cell Mol Med (2006) 1.04
Regulation of fibroblast procollagen production. Transforming growth factor-beta 1 induces prostaglandin E2 but not procollagen synthesis via a pertussis toxin-sensitive G-protein. Biochem J (1995) 1.00
Elevated synthesis of biglycan and decorin in an ovine annular lesion model of experimental disc degeneration. Eur Spine J (1997) 0.87
Experimental models of liver fibrosis. Arch Toxicol (2015) 0.78
Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus. Nat Cell Biol (2001) 3.67
The phosphorylation of liver ribosomal proteins in vivo. Evidence that only a single small subunit protein (S6) is phosphorylated. J Biol Chem (1974) 2.40
Properties of purified Orange II azoreductase, the enzyme initiating azo dye degradation by Pseudomonas KF46. Eur J Biochem (1982) 2.18
Role of NFkappaB in the mortality of sepsis. J Clin Invest (1997) 2.18
Net costs of dementia by disease stage. Acta Psychiatr Scand (2011) 2.11
Practical implications of coexistent different technologies in clinical chemical laboratories. Solid phase chemistry and conventional analysis. Eur J Clin Chem Clin Biochem (1991) 1.96
Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology (2000) 1.84
The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology (1987) 1.84
Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest (1992) 1.62
Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin Immunol Immunopathol (1992) 1.51
Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol (1997) 1.51
Successful treatment of Erdheim-Chester disease with combination of interleukin-1-targeting drugs and high-dose glucocorticoids. Intern Med J (2014) 1.42
[Palliative therapy of primary liver tumors]. Langenbecks Arch Chir (1993) 1.40
[The clinical value of laminin determination in advanced liver cirrhosis]. Dtsch Med Wochenschr (1996) 1.39
Nitroglycerin to facilitate fetal extraction during cesarean delivery. Obstet Gynecol (1998) 1.38
Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison. Clin Chem (1997) 1.35
Comparison of two bacterial azoreductases acquired during adaptation to growth on azo dyes. Arch Microbiol (1984) 1.31
Tracheobronchial aspiration of foreign bodies in children: a study of 94 cases. Laryngoscope (1990) 1.29
Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology (2001) 1.29
Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology (2006) 1.28
Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. Gen Pharmacol (1997) 1.28
Sex differences in 'climacteric symptoms' with increasing age? A hypothesis-generating analysis of cross-sectional population surveys. Aging Male (2000) 1.25
Thioacetamide-induced cirrhosis-like liver lesions in rats--usefulness and reliability of this animal model. Exp Pathol (1988) 1.25
Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology (1997) 1.23
Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. Antimicrob Agents Chemother (1996) 1.21
Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology (1998) 1.19
Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Growth Factors (2005) 1.18
Tumor necrosis factor alpha (TNF alpha) and transforming growth factor beta 1 (TGF beta 1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 1.15
Influence of glucagon and cyclic adenosine 3':5'-monophosphate on the phosphorylation of rat liver ribosomal protein S6. J Biol Chem (1976) 1.11
Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells. Gut (2005) 1.11
Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany. Mycoses (1999) 1.08
Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J Cell Mol Med (2007) 1.07
Distribution of orally administered azithromycin in various blood compartments. Int J Clin Pharmacol Ther (1994) 1.07
Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture. Hepatology (2001) 1.06
The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int J Immunogenet (2007) 1.06
Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis. J Viral Hepat (2009) 1.05
Molecular and functional aspects of latent transforming growth factor-beta binding protein: just a masking protein? Cell Tissue Res (1999) 1.04
The stimulation of the phosphorylation of ribosomal protein S6 by cycloheximide and puromycin. Biochem Biophys Res Commun (1974) 1.03
Biochemical and morphological studies on production and regression of experimental liver cirrhosis induced by thioacetamide in Uje: WIST rats. Z Versuchstierkd (1987) 1.03
Serum concentrations of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases. Clin Chim Acta (1986) 1.00
Rapid genotyping of hemochromatosis gene mutations on the LightCycler with fluorescent hybridization probes. Clin Chem (1999) 0.99
Cellular distribution and function of soluble guanylyl cyclase in rat kidney and liver. J Am Soc Nephrol (2001) 0.99
[Low T3 syndrome in multiple trauma patients--a phenomenon or important pathogenetic factor?]. Med Klin (Munich) (1999) 0.98
Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol (1996) 0.98
Interaction of synthetic polynucleotides with small rat liver ribosomal subunits possessing low and highly phosphorylated protein S6. Biochim Biophys Acta (1980) 0.97
Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. Differentiation (2008) 0.97
Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation. Clin Biochem (2007) 0.97
Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation. Biochem Biophys Res Commun (2006) 0.97
Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts. Biochem Biophys Res Commun (2001) 0.94
LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1. Biochem J (2001) 0.94
Bioavailability of fluconazole in the skin after oral medication. Mycoses (1995) 0.94
Effect of experimental diabetes and insulin on phosphorylation of rat liver ribosomal protein S6. Nature (1976) 0.93
Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception (2004) 0.93
Fibronectin is synthesized as an acute phase reactant in rat hepatocytes. J Clin Chem Clin Biochem (1986) 0.93
Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling. J Cell Mol Med (2006) 0.93
[Effects of standardized Myrtol in therapy of acute sinusitis--results of a double-blind, randomized multicenter study compared with placebo]. Laryngorhinootologie (1997) 0.93
Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha. Biochem Biophys Res Commun (1990) 0.93
(Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells. Hepatology (1998) 0.93
Measurement of proteins with the Behring Nephelometer. A multicentre evaluation. J Clin Chem Clin Biochem (1989) 0.92
Characterization of insulin-like growth factor (IGF)-I-receptor binding sites during in vitro transformation of rat hepatic stellate cells to myofibroblasts. Eur J Clin Chem Clin Biochem (1996) 0.92
Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta. Biochem Biophys Res Commun (1989) 0.92
Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy. Neurology (2001) 0.92
Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery. Br J Nutr (2002) 0.91
Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. Gastroenterology (1997) 0.91
Insulin-like growth factor signaling pathways in rat hepatic stellate cells: importance for deoxyribonucleic acid synthesis and hepatocyte growth factor production. Endocrinology (1999) 0.91
[Doubtful evidence for the use of the cholinesterase inhibitor donepezil in patients with dementia--a systematic review]. Fortschr Neurol Psychiatr (2004) 0.90
Differential expression of keratan sulphate proteoglycans fibromodulin, lumican and aggrecan in normal and fibrotic rat liver. FEBS Lett (1992) 0.90
Preventive effects of acute inflammation on liver cell necrosis and inhibition of heparan sulphate synthesis in hepatocytes. J Clin Chem Clin Biochem (1986) 0.90
Comparative pharmacokinetics of fluconazole and of itraconazole in Japanese and in German subjects. Int J Clin Pharmacol Ther (1995) 0.90
Quantitative monitoring of the mRNA expression pattern of the TGF-beta-isoforms (beta 1, beta 2, beta 3) during transdifferentiation of hepatic stellate cells using a newly developed real-time SYBR Green PCR. Biochem Biophys Res Commun (2002) 0.89
Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells. Hepatology (1998) 0.89
Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum. Clin Chem (1991) 0.89
[Decreasing mortality in acute pancreatitis with sodium selenite. Clinical results of 4 years antioxidant therapy]. Med Klin (Munich) (1995) 0.88
Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer. Pancreas (2000) 0.88
The role of thrombocytes in liver fibrogenesis: effects of platelet lysate and thrombocyte-derived growth factors on the mitogenic activity and glycosaminoglycan synthesis of cultured rat liver fat storing cells. J Clin Chem Clin Biochem (1989) 0.88
The response of rat liver perisinusoidal lipocytes to polypeptide growth regulator changes with their transdifferentiation into myofibroblast-like cells in culture. J Hepatol (1993) 0.88
Studies on the lipid metabolism using 14C-1-palmitate in fetal rats. Biol Neonate (1974) 0.87
Enhancing filtration rates by the use of blood flow around the capillaries of plasmafilters: an in vitro study. Int J Artif Organs (2001) 0.87
Insulin-like growth factors stimulate expression of hepatocyte growth factor but not transforming growth factor beta1 in cultured hepatic stellate cells. Endocrinology (1997) 0.87
The chemical morphology of extracellular matrix in experimental rat liver fibrosis resembles that of normal developing connective tissue. Virchows Arch (1994) 0.87
Comparison of the pharmacokinetics of three-day and five-day regimens of azithromycin in plasma and urine. J Antimicrob Chemother (1993) 0.87
Liver transplantation for hepatocellular carcinoma--is there a risk of recurrence caused by intraoperative blood salvage autotransfusion? Eur Surg Res (2011) 0.87
Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem (2001) 0.86
Comparative analysis of adenoviral transgene delivery via tail or portal vein into rat liver. Arch Virol (2004) 0.86
Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem (2000) 0.86
Mosaic chromosomal aberrations in synovial fibroblasts of patients with rheumatoid arthritis, osteoarthritis, and other inflammatory joint diseases. Arthritis Res (2001) 0.86
Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility. Mycoses (1997) 0.86
Biglycan and decorin gene expression in normal and fibrotic rat liver: cellular localization and regulatory factors. Hepatology (1992) 0.86
Expression of isoforms and splice variants of the latent transforming growth factor beta binding protein (LTBP) in cultured human liver myofibroblasts. Liver (2001) 0.86
Pharmacokinetics and tolerance of fluconazole suppositories in healthy volunteers. Arzneimittelforschung (1993) 0.86
Proliferation of fat-storing cells is stimulated by secretions of Kupffer cells from normal and injured liver. Exp Mol Pathol (1988) 0.85
The prognostic value of extracellular matrix component concentrations in serum during treatment of adult respiratory distress syndrome with extracorporeal CO2 removal. Eur J Clin Chem Clin Biochem (1991) 0.85
Identification of an unconventional nuclear localization signal in human ribosomal protein S2. Biochem Biophys Res Commun (2005) 0.85
Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial. Curr Med Res Opin (2004) 0.85
Gene expression of syndecans and betaglycan in isolated rat liver cells. Cell Tissue Res (1996) 0.85
Expression of different isoforms of TGF-beta and the latent TGF-beta binding protein (LTBP) by rat Kupffer cells. J Hepatol (1998) 0.85
Influence of fibronectin on the motility of human spermatozoa. Int J Androl (1997) 0.84